Do Cyclooxygenase-2 Inhibitors Provide Benefits Similar to Those of Traditional Nonsteroidal Anti-Inflammatory Drugs, with Less Gastrointestinal Toxicity?
- 18 January 2000
- journal article
- review article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 132 (2), 134-143
- https://doi.org/10.7326/0003-4819-132-2-200001180-00008
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- COX-2 inhibitorsThe Lancet, 1999
- Multiple Female Reproductive Failures in Cyclooxygenase 2–Deficient MiceCell, 1997
- Efficacy and Tolerability of Intramuscular and Oral Meloxicam in Patients with Acute Lumbago: A Comparison with Intramuscular and Oral PiroxicamCurrent Medical Research and Opinion, 1997
- Meloxicam in Osteoarthritis: A 6-Month, Double-Blind Comparison with Diclofenac SodiumRheumatology, 1996
- A Double-Blind Study to Compare the Efficacy and Safety of Meloxicam 15 mg with Piroxicam 20 mg in Patients with Osteoarthritis of the HIPRheumatology, 1996
- A Six-Month Double-Blind Trial to Compare the Efficacy and Safety of Meloxicam 7.5 mg Daily and Naproxen 750 mg Daily in Patients with Rheumatoid ArthritisRheumatology, 1996
- The efficacy and tolerability of an 8-day administration of intravenous and oral meloxicam: A comparison with intramuscular and oral diclofenac in patients with acute lumbagoCurrent Medical Research and Opinion, 1996
- NabumetoneDrugs, 1993
- Nimesulide in the Treatment of OsteoarthritisDrugs, 1993
- A Double-Blind Study of the Efficacy of Nimesulide in the Treatment of Ankle Sprain in Comparison with PlaceboDrugs, 1993